January 16, 2017 by Mark Baumgartner and Chain Drug Review
Domenic Pilla, John Hammergren, Jürgen Schreiber, McKesson, McKesson Canada, Paul Julian, Rexall Health, Shoppers Drug Mart
2017, Issue 01-16-2017, Issues, News
TORONTO — Domenic Pilla has been appointed chief executive officer of McKesson Canada. Pilla now guides Canada’s largest distributor of pharmaceuticals and medical supplies and oversees the integration of Rexall Health, which McKesson Canada acquired in late December. McKesson Canada picked up about 470 retail pharmacies in the Rexall deal. Pilla reports to Paul Julian,
December 29, 2016 by Chain Drug Review
Daryl Katz, Domenic Pilla, John Hammergren, Jürgen Schreiber, Katz Group, McKesson, McKesson Canada, Paul Julian, Paula Keays, Rexall Health
Business, Featured Articles, Leading Headlines, Retail News
SAN FRANCISCO and TORONTO — McKesson Corp. has closed its $2.1 billion (U.S.) acquisition of Canadian drug chain Rexall Health and hired Domenic Pilla as chief executive officer of McKesson Canada. McKesson said late Wednesday that Pilla is slated to take the reins as McKesson Canada CEO on Jan. 3. In the role, he will
April 20, 2016 by Chain Drug Review
Gerry Stefanatos, Jürgen Schreiber, medication adherence, medication synchronization, OneStopMeds, Pfizer Canada, Rexall
Leading Headlines, Pharmacy, Retail News
KIRKLAND, Quebec — Pfizer Canada has partnered with Canadian drug chain Rexall on its OneStopMeds medication synchronization program. Pfizer said Wednesday that through the med sync program, launched by Rexall in January, it aims to work with the drug chain to help improve medication adherence and health outcomes for patients taking multiple chronic medications. Patients
March 14, 2016 by Geoff Walden and Chain Drug Review
Alain Champagne, Daryl Katz, John Hammergren, Jürgen Schreiber, Katz Group, McKesson, McKesson Canada, Paul Julian, Rexall Health
2016, Issue 03-14-2016, Issues, News
TORONTO — McKesson Corp.’s $2.2 billion deal to acquire Rexall Health from Katz Group will strengthen the drug distributor’s position in Canada’s pharmaceutical supply chain. McKesson said the agreement is a natural next step for two companies that have worked together for over 20 years. In 2012, McKesson bought Katz’s 1,100-store banner operation covering I.D.A.,
March 2, 2016 by John Schultz and Chain Drug Review
Daryl Katz, John Hammergren, Jürgen Schreiber, Katz Group, McKesson, McKesson Canada, Paul Julian, Rexall Health
Business, Featured Articles, Leading Headlines, Retail News
SAN FRANCISCO and TORONTO — McKesson Corp. plans to acquire Canadian drug store operator Rexall Health from Katz Group for $2.2 billion ($3 billion Canadian). McKesson said Wednesday that the deal will strengthen its position in Canada’s pharmaceutical supply chain and is a natural step for the two companies, which have worked together for more
February 22, 2016 by Mark Baumgartner and Chain Drug Review
Ateb Canada, Frank Sheppard, Jürgen Schreiber, medication synchronization, OneStopMeds, Rexall Health, Time My Meds
2016, Issue 02-22-2016, Issues, News
MISSISSAUGA, Ontario — Rexall Health and Ateb Canada Ltd. are partnering on a medication synchronization program aimed at improving medication adherence and health outcomes for patients with multiple chronic conditions. The service, OneStopMeds, uses Ateb technology to help Rexall’s pharmacists coordinate a patient’s prescriptions so each is refilled on the same day of the month,
January 25, 2016 by Chain Drug Review
Ateb, Frank Sheppard, Jürgen Schreiber, medication synchronization, OneStopMeds, Rexall, Rexall Health, Time My Meds
Featured Articles, Leading Headlines, Pharmacy, Retail News, Videos
MISSISSAUGA, Ontario — Rexall has launched a medication synchronization program for 445 of its pharmacies across Canada. Called OneStopMeds, the med sync program is powered by Ateb’s Time My Meds solution. Rexall said Monday that it’s the first retail pharmacy in Canada to offer this service to patients in multiple provinces. To participate in the
June 15, 2015 by Chain Drug Review
Daryl Katz, Jürgen Schreiber, Katz Group, Rexall Health, Shoppers Drug Mart
2015, Issue 06-15-2015, News
EDMONTON, Alberta — Canada’s Rexall/Rexall Pharma Plus drug chain has a new chief executive officer and a new operating structure. Former Shoppers Drug Mart chief executive Jürgen Schreiber has been named CEO of Rexall Health, a newly formed banner under the Katz Group. Plans call for Schreiber, who joins the company from Edcon Group, South
May 28, 2015 by John Schultz and Chain Drug Review
Claimsecure, Daryl Katz, Edcon Group, Jürgen Schreiber, Katz Group, Medicentres Canada, Rexall, Rexall Health, Rexall Pharma Plus
Business, Featured Articles, Leading Headlines, Retail News
EDMONTON, Alberta – Former Shoppers Drug Mart chief executive officer Jürgen Schreiber has been named CEO of Rexall Health, a newly formed banner under the Katz Group. Rexall said Thursday that Schreiber, who joins the company from Edcon Group, South Africa’s largest nonfood retailer, is slated to take the helm as CEO in August. In
October 4, 2011 by Chain Drug Review
David Williams, Domenic Pilla, Holger Kluge, Jürgen Schreiber, McKesson Canada, Shoppers Drug Mart
Business, Retail News
TORONTO — After a seven-month search, Shoppers Drug Mart Corp. has appointed Domenic Pilla as president and chief executive officer. Canada’s largest drug store chain said late Monday that Pilla, who most recently was president of McKesson Canada, will take the helm as CEO on Nov. 1. He also will serve as a director on
January 27, 2011 by Chain Drug Review
Brad Lukow, David Williams, Jürgen Schreiber, Mary-Alice Vuicic, Mike Motz, Pharmaprix, Shoppers Drug Mart
Business, Retail News
TORONTO — Jürgen Schreiber, president and chief executive officer of Shoppers Drug Mart Corp., is slated to resign next month, and the company has begun a search for his replacement. Shoppers Drug Mart said Thursday that plans call for Schreiber, who’s also a board director, to leave the company on Feb. 15. Schreiber aims to